•
Sep 30, 2019

CervoMed Q3 2019 Earnings Report

EPS
-$30
Previous year: -$6.5
+361.5%
R&D Expenses
$1.7M
G&A Expenses
$1.3M
Cash and Equivalents
$6.14M
Previous year: $11M
-44.3%
Total Assets
$16.2M
Previous year: $23.6M
-31.4%

CervoMed

CervoMed